Global Burden of Ovarian and Uterine Cancer Attributable to High BMI, 1990-2021

Data from the Global Burden of Disease 2021 study quantifies the mortality and disability-adjusted life-years (DALYs) for ovarian and uterine cancer linked to high body mass index. Xi Wang authored this analysis, which includes estimates for early-onset (<50 years) and late-onset (≥50 years) cases from 1990 to 2021. Future trends in mortality and DALYs are projected from 2022 to 2050 using Bayesian age-period-cohort analysis.

Use Cases

• Analyze temporal trends in cancer burden based on mortality and DALY metrics from 1990 to 2021
• Compare disease burden between early-onset and late-onset cancer cases based on age-stratified data
• Project future mortality and DALY trends for ovarian and uterine cancer based on Bayesian age-period-cohort analysis
• Assess regional variations in cancer burden based on socio-demographic index (SDI) stratification

Strengths

• Data spans a 32-year period from 1990 to 2021
• Includes specific metrics like mortality, DALYs, and average annual percentage change (AAPC) with confidence intervals
• Stratifies data by age of onset (early vs. late) and socio-demographic index (SDI) regions

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data is provided in a DOCX file format, which may require extraction for analysis

Provenance

Source

Global Burden of Disease (GBD) 2021 study

Collection Method

Extracted and analyzed from GBD 2021 data; future trends projected using Bayesian age-period-cohort analysis

Time Range

1990-2021, with projections to 2050

Freshness

Last updated 2026-05-28 04:45:29; freshness should be verified

Geography

Global, regional, and national levels